First, similar to several other lncRNA markers, both ZFAS1 and CDR1AS were found to be upregulated in cancer patients,239,240 suggesting that cancer is a confounder and might hamper ZFAS1 and CDR1AS diagnostic specificity. This evidence concerns the gene ZFAS1 and cancer.